Grant List
Represents Grant table in the DB
GET /v1/grants?page%5Bnumber%5D=1405&sort=award_id
{ "links": { "first": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1&sort=award_id", "last": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1424&sort=award_id", "next": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1406&sort=award_id", "prev": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1404&sort=award_id" }, "data": [ { "type": "Grant", "id": "7809", "attributes": { "award_id": "75N93019C00074-P00001-9999-2", "title": "B-CELL EPITOPE DISCOVERY AND MECHANISMS OF ANTIBODY PROTECTION: Modification for SARS-CoV2 Research", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Allergy and Infectious Diseases (NIAID)" ], "program_reference_codes": [], "program_officials": [], "start_date": "2019-09-16", "end_date": "2021-02-17", "award_amount": 3033590, "principal_investigator": { "id": 23619, "first_name": "JAMES", "last_name": "CROWE", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 456, "ror": "https://ror.org/05dq2gs74", "name": "Vanderbilt University Medical Center", "address": "", "city": "", "state": "TN", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 456, "ror": "https://ror.org/05dq2gs74", "name": "Vanderbilt University Medical Center", "address": "", "city": "", "state": "TN", "zip": "", "country": "United States", "approved": true }, "abstract": "This contract supports the identification of human B cell epitopes derived from SARS-CoV2", "keywords": [ "2019-nCoV", "Antibodies", "B-Lymphocyte Epitopes", "Epitope Mapping", "Human", "Modification", "Research", "Support Contracts", "human monoclonal antibodies" ], "approved": true } }, { "type": "Grant", "id": "9519", "attributes": { "award_id": "75N93019C00076-P00003-9999-2", "title": "BIOINFORMATICS RESOURCE CENTERS FOR INFECTIOUS DISEASES: SARS-CoV-2 ACTIVITIES", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Allergy and Infectious Diseases (NIAID)" ], "program_reference_codes": [], "program_officials": [], "start_date": "2019-09-15", "end_date": "2022-09-14", "award_amount": 511450, "principal_investigator": { "id": 25227, "first_name": "RICK", "last_name": "STEVENS", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 289, "ror": "https://ror.org/024mw5h28", "name": "University of Chicago", "address": "", "city": "", "state": "IL", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 289, "ror": "https://ror.org/024mw5h28", "name": "University of Chicago", "address": "", "city": "", "state": "IL", "zip": "", "country": "United States", "approved": true }, "abstract": "The Bioinformatics Resource Centers for Infectious Diseases provide facilities, equipment, qualified personnel, and all necessary resources and services to collect, archive, update, integrate, and maintain a variety of research data from infectious diseases pathogens, and to provide for the query, analysis and display of such information through user friendly interfaces and computational analyses tools made freely available to the scientific community.", "keywords": [ "2019-nCoV", "Archives", "Basic Science", "Communicable Diseases", "Communities", "Computer Analysis", "Coronavirus", "Data", "Equipment", "Human Resources", "Research", "Resources", "Services", "Update", "bioinformatics resource", "pathogen", "public health relevance", "tool", "user-friendly" ], "approved": true } }, { "type": "Grant", "id": "9520", "attributes": { "award_id": "75N93019C00076-P00003-9999-4", "title": "BIOINFORMATICS RESOURCE CENTERS FOR INFECTIOUS DISEASES: SARS-CoV-2 ACTIVITIES", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Allergy and Infectious Diseases (NIAID)" ], "program_reference_codes": [], "program_officials": [], "start_date": "2019-09-15", "end_date": "2022-09-14", "award_amount": 620399, "principal_investigator": { "id": 25227, "first_name": "RICK", "last_name": "STEVENS", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 289, "ror": "https://ror.org/024mw5h28", "name": "University of Chicago", "address": "", "city": "", "state": "IL", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 289, "ror": "https://ror.org/024mw5h28", "name": "University of Chicago", "address": "", "city": "", "state": "IL", "zip": "", "country": "United States", "approved": true }, "abstract": "The Bioinformatics Resource Centers for Infectious Diseases provide facilities, equipment, qualified personnel, and all necessary resources and services to collect, archive, update, integrate, and maintain a variety of research data from infectious diseases pathogens, and to provide for the query, analysis and display of such information through user friendly interfaces and computational analyses tools made freely available to the scientific community.", "keywords": [ "2019-nCoV", "Archives", "Basic Science", "Communicable Diseases", "Communities", "Computer Analysis", "Data", "Equipment", "Human Resources", "Research", "Resources", "Services", "Update", "bioinformatics resource", "pathogen", "tool", "user-friendly" ], "approved": true } }, { "type": "Grant", "id": "8292", "attributes": { "award_id": "75N93019D00021-0-759302100001-2", "title": "Task B6: In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses, Including SARS-CoV-2", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Allergy and Infectious Diseases (NIAID)" ], "program_reference_codes": [], "program_officials": [], "start_date": "2021-05-03", "end_date": "2022-05-02", "award_amount": 272532, "principal_investigator": { "id": 22787, "first_name": "BRETT", "last_name": "HURST", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 375, "ror": "https://ror.org/00h6set76", "name": "Utah State University", "address": "", "city": "", "state": "UT", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 375, "ror": "https://ror.org/00h6set76", "name": "Utah State University", "address": "", "city": "", "state": "UT", "zip": "", "country": "United States", "approved": true }, "abstract": "This contract provides in vitro testing of potential anti-viral agents, maintenance of viral stocks and cell lines needed to grow the viruses, and development of related assays.", "keywords": [ "2019-nCoV", "Antiviral Agents", "Biological Assay", "COVID-19 therapeutics", "Cell Line", "Contracts", "In Vitro", "Maintenance", "Middle East Respiratory Syndrome Coronavirus", "SARS coronavirus", "Viral", "antimicrobial", "in vitro testing", "respiratory virus", "therapeutic evaluation", "virus development" ], "approved": true } }, { "type": "Grant", "id": "15341", "attributes": { "award_id": "75N93019D00021-0-759302400002-2", "title": "Task B25: In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses, SARS-CoV-2", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Allergy and Infectious Diseases (NIAID)" ], "program_reference_codes": [], "program_officials": [], "start_date": "2024-09-23", "end_date": "2025-09-22", "award_amount": 206532, "principal_investigator": { "id": 22787, "first_name": "BRETT", "last_name": "HURST", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 375, "ror": "https://ror.org/00h6set76", "name": "Utah State University", "address": "", "city": "", "state": "UT", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 375, "ror": "https://ror.org/00h6set76", "name": "Utah State University", "address": "", "city": "", "state": "UT", "zip": "", "country": "United States", "approved": true }, "abstract": "This contract provides in vitro testing of potential anti-viral agents, maintenance of viral stocks and cell lines needed to grow the viruses, and development of related assays.", "keywords": [], "approved": true } }, { "type": "Grant", "id": "6939", "attributes": { "award_id": "75N93019D00021-P00001-759302100001-2", "title": "Task B6: In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses, Including SARS-CoV-2", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Allergy and Infectious Diseases (NIAID)" ], "program_reference_codes": [], "program_officials": [], "start_date": "2021-05-03", "end_date": "2022-05-02", "award_amount": 13750, "principal_investigator": { "id": 22787, "first_name": "BRETT", "last_name": "HURST", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 375, "ror": "https://ror.org/00h6set76", "name": "Utah State University", "address": "", "city": "", "state": "UT", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 375, "ror": "https://ror.org/00h6set76", "name": "Utah State University", "address": "", "city": "", "state": "UT", "zip": "", "country": "United States", "approved": true }, "abstract": "This contract provides in vitro testing of potential anti-viral agents, maintenance of viral stocks and cell lines needed to grow the viruses, and development of related assays.", "keywords": [ "2019-nCoV", "Advanced Development", "Antiviral Agents", "Avian Influenza", "Biological Assay", "COVID-19 therapeutics", "Cell Line", "Contracts", "Coronavirus", "In Vitro", "Influenza A virus", "Maintenance", "Viral", "antimicrobial", "in vitro testing", "respiratory virus", "virus development" ], "approved": true } }, { "type": "Grant", "id": "9142", "attributes": { "award_id": "75N93020C00022-0-9999-1", "title": "DEVELOPMENT OF FERRET REAGENTS FOR USE IN THE CHARACTERIZATION OF IMMUNE RESPONSES TO RESPIRATORY INFECTIONS IN THE FERRET MODEL.", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Allergy and Infectious Diseases (NIAID)" ], "program_reference_codes": [], "program_officials": [], "start_date": "2020-07-01", "end_date": "2022-06-30", "award_amount": 572817, "principal_investigator": { "id": 24917, "first_name": "TORI", "last_name": "RACE", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [], "awardee_organization": null, "abstract": "Ferrets represent excellent models of human respiratory viruses such as influenza A virus, SARS-CoV and MERS-CoV. The goal of this proposal is to generate antibodies for analyzing immune cells and cytokine responses during respiratory infections in ferrets. The main focuses are immune cell markers and cytokines produced by these cells during immune responses. The contractor plans to use standard hybridoma techniques to generated monoclonal antibodies will then undergo extensive immunological characterization using various methods to show the specificity to recombinant immunogens as well as selected ferret samples.", "keywords": [ "Antibodies", "Antigens", "Cells", "Contractor", "Ferrets", "Generations", "Goals", "Hybridomas", "Immune", "Immune response", "Immunization", "Immunologics", "Influenza A virus", "Methods", "Middle East Respiratory Syndrome Coronavirus", "Modeling", "Monoclonal Antibodies", "Mus", "Proteins", "Reagent", "Recombinants", "Respiratory Tract Infections", "SARS coronavirus", "Sampling", "Specificity", "Techniques", "Validation", "cytokine", "human model", "respiratory virus", "response" ], "approved": true } }, { "type": "Grant", "id": "9090", "attributes": { "award_id": "75N93020C00032-0-9999-2", "title": "COVID-19: Clinical Research Products Development Center (CRPMC)", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Allergy and Infectious Diseases (NIAID)" ], "program_reference_codes": [], "program_officials": [], "start_date": "2020-06-16", "end_date": "2021-06-15", "award_amount": 1196744, "principal_investigator": { "id": 24891, "first_name": "NEERAJA", "last_name": "PUTTA", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 1795, "ror": "", "name": "FISHER BIOSERVICES, INC.", "address": "", "city": "", "state": "MD", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 1795, "ror": "", "name": "FISHER BIOSERVICES, INC.", "address": "", "city": "", "state": "MD", "zip": "", "country": "United States", "approved": true }, "abstract": "NIAID has a requirement for the management and operation of a Clinical Research Products Management Center (CRPMC) to support NIAID-sponsored clinical research trials both domestically and internationally. This contract will provide pharmaceutical services and study product management by providing a cGMP-compliant facility, receipt, storage, labeling, packaging, repackaging, shipping, acquiring, and disposition of study products. This contract will provide cognitive pharmaceutical services including evaluating draft protocols; reviewing site pharmacy monitoring reports and maintaining a site audit pharmacy report database; providing study product storage and stability information, guidance in research pharmacy practice and study product management activities to clinical site pharmacists; and conducting Current Good Manufacturing Practice (cGMP) audits of manufacturing facilities. This project will support study product management and distribution of the study products for COVID-19 clinical trial A5401 (ACTIV-2 Outpatient Monoclonal Antibodies And Other Therapies).", "keywords": [ "AIDS clinical trial group", "COVID-19", "Clinical Research", "Clinical Trials", "Cognitive", "Contracts", "Databases", "International", "Label", "Monitor", "Monoclonal Antibodies", "National Institute of Allergy and Infectious Disease", "Outpatients", "Pharmaceutical Services", "Pharmacists", "Pharmacy facility", "Protocols documentation", "Reporting", "Research", "Shipping", "Site", "clinical research site", "manufacturing facility", "operation", "product development" ], "approved": true } }, { "type": "Grant", "id": "9091", "attributes": { "award_id": "75N93020C00032-P00003-9999-2", "title": "COVID-19: Clinical Research Products Management Center (CRPMC)", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Allergy and Infectious Diseases (NIAID)" ], "program_reference_codes": [], "program_officials": [], "start_date": "2020-06-16", "end_date": "2021-06-15", "award_amount": 2273031, "principal_investigator": { "id": 24892, "first_name": "CARINA", "last_name": "REMGSAMAI-NHE", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 1795, "ror": "", "name": "FISHER BIOSERVICES, INC.", "address": "", "city": "", "state": "MD", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 1795, "ror": "", "name": "FISHER BIOSERVICES, INC.", "address": "", "city": "", "state": "MD", "zip": "", "country": "United States", "approved": true }, "abstract": "NIAID has a requirement for the management and operation of a Clinical Research Products Management Center (CRPMC) to support NIAID-sponsored clinical research trials both domestically and internationally. This contract will provide pharmaceutical services and study product management by providing a cGMP-compliant facility, receipt, storage, labeling, packaging, repackaging, shipping, acquiring, and disposition of study products. This contract will provide cognitive pharmaceutical services including evaluating draft protocols; reviewing site pharmacy monitoring reports and maintaining a site audit pharmacy report database; providing study product storage and stability information, guidance in research pharmacy practice and study product management activities to clinical site pharmacists; and conducting Current Good Manufacturing Practice (cGMP) audits of manufacturing facilities. This project will support study product management and distribution of the study products for COVID-19 clinical trial A5401 (ACTIV-2 Outpatient Monoclonal Antibodies And Other Therapies).", "keywords": [ "AIDS clinical trial group", "COVID-19", "Clinical Research", "Clinical Trials", "Cognitive", "Contracts", "Databases", "International", "Label", "Monitor", "Monoclonal Antibodies", "National Institute of Allergy and Infectious Disease", "Outpatients", "Pharmaceutical Services", "Pharmacists", "Pharmacy facility", "Protocols documentation", "Reporting", "Research", "Shipping", "Site", "clinical research site", "manufacturing facility", "operation" ], "approved": true } }, { "type": "Grant", "id": "9168", "attributes": { "award_id": "75N93020C00051-0-9999-1", "title": "Manufacture of SARS-CoV-2 Human Challenge Material", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Allergy and Infectious Diseases (NIAID)" ], "program_reference_codes": [], "program_officials": [], "start_date": "2020-08-17", "end_date": "2021-08-16", "award_amount": 3601220, "principal_investigator": { "id": 24931, "first_name": "RAY", "last_name": "GOODRICH", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 323, "ror": "https://ror.org/03k1gpj17", "name": "Colorado State University", "address": "", "city": "", "state": "CO", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 323, "ror": "https://ror.org/03k1gpj17", "name": "Colorado State University", "address": "", "city": "", "state": "CO", "zip": "", "country": "United States", "approved": true }, "abstract": "To manufacture SARS-CoV-2 Human Challenge Material (HCM) that could be used in Challenge Human Infection Model (CHIM) studies.", "keywords": [ "2019-nCoV", "COVID-19", "Human", "Infection", "Study models", "vaccine development" ], "approved": true } } ], "meta": { "pagination": { "page": 1405, "pages": 1424, "count": 14236 } } }